Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC)
Closed
Phase 1
This trial is for people with non small cell lung cancer that has spread and has a change in the ALK protein.
Recruitment start: 28 December 2015
Recruitment end: 23 October 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Alastair Greystoke
Experimental Cancer Medicine Centre (ECMC)
Novartis
Last reviewed: 03 Jan 2018
CRUK internal database number: 13655